nyse

AbbVie (NYSE: ABBV), one of the world’s largest pharmaceutical companies, is usually considered a blue chip dividend stock…

Quick Read Welltower (WELL) delivered 22.1% same-store NOI growth and its 220th consecutive quarterly dividend, while Healthpeak (DOC)…

Quick Read Pfizer’s 7% yield and forward P/E of 8 complement Viatris’s three FDA PDUFA decisions arriving before…

The property market research group, Cotality, has tabulated the final results from the weekend’s home auctions and found…

Wall Street got a reality check as a bruising sell-off in several technology giants fuelled concern the artificial…

Quick Read Bank of America forecasts 75 basis points of Fed rate hikes through 2026, citing sticky inflation…

Oklo (NYSE: OKLO) and NuScale Power (NYSE: SMR) are trying to build businesses around small modular nuclear reactors…

Forget rate cuts. They aren’t coming anytime soon. Instead, the probability of rate hikes is rising, based on…

Quick Read NVO sits 44% below its 52-week high with a price-to-free-cash-flow of 5 and a free cash…

Artificial intelligence has helped push major indexes to fresh highs. But according to Jim Cramer (1), that momentum…

Economic downturns cast a wide net across the market, and there’s no stock that’s completely immune to a…

In his last quarter as CEO of Berkshire Hathaway (NYSE: BRKB), legendary investor Warren Buffett made one very…

AbbVie Has Raised Its Dividend for 53 Straight Years and Still Looks Attractively Valued. Is This Dividend King the Smartest Buy in Healthcare Right Now?